As the world watches progress on the approval and implementation of new coronavirus vaccines around the world, investors are looking closely at what an effective vaccine may mean for the global markets and economy.
Our global investment research team recently shared perspective on current financial conditions across global equity and fixed income markets, how much of vaccine optimism is priced into today’s markets and what we could see in 2021.
Read the full blog post now at the link below
The past five years in US markets have been nothing if not eventful. They’ve featured every macro regime of the economic cycle, where markets weathered a global pandemic, quantitative tightening and easing, inflation, and both low and rising rate environments.
Just 50 years ago, Taiwan was a labour-intensive manufacturing hub for cheap exports such as textiles and toys. In the 1980s, it successfully transformed into a vibrant advanced electronics manufacturing hub that continues to play an important role in the global technology shift of the past decade. Crucially, Taiwan has developed into one of the world’s most critical semiconductor manufacturing centres, and the semiconductor industry has become an inseparable component of Taiwan’s economic growth.
In 1984, FTSE Russell (at the time Russell Indexes) introduced the Russell 3000® Index, the first of its kind to provide institutional investors with a comprehensive, accurate and objective representation of the world’s largest and most liquid (US) equity market.
Copyright © 1997–2022 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP
